TERT启动子突变在多形性黄色星形细胞瘤恶性转化中的作用
本文报告一例复发性多形性黄色星形细胞瘤(PXA),在首次肿瘤复发接受立体定向放射外科(SRS)治疗后,于第二次手术标本中检出TERT启动子突变,随后在第二次复发时发生间变性多形性黄色星形细胞瘤(A-PXA)恶性转化,肿瘤此后反复复发。作者认为TERT启动子突变可能促进PXA恶性转化,机制不明,可能由SRS引起,故应避免不恰当的放射治疗以防PXA恶性转化。
要点
- 本例在SRS后第二次手术标本中检出TERT启动子突变。
- 第二次复发时发生A-PXA恶性转化,肿瘤此后反复复发。
- 作者认为TERT启动子突变可能促进PXA恶性转化,机制不明。
核心结论
- TERT启动子突变可能促进PXA恶性转化,该突变机制不明,可能由SRS引起。
- 作者认为应避免不恰当地使用放射治疗,以防止PXA恶性转化。
研究设计与样本
- 个案报告,报告一例复发性PXA并系统检查其恶性转化过程中的基因时间变化。
主要发现
- 首次肿瘤复发接受SRS后,第二次手术标本中检出TERT启动子突变。
- 第二次复发时发生向A-PXA的恶性转化,肿瘤此后反复复发。
临床怎么用
- 作者认为应避免不恰当地使用放射治疗,以防止PXA恶性转化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pleomorphic xanthoastrocytoma (PXA) is categorized as grade II, other astrocytic tumors per the 2016 World Health Organization classification. Despite being a relatively benign type of tumor, PXA often has an aggressive clinical course. The more malignant form of PXA is now known as anaplastic pleomorphic xanthoastrocytoma (A-PXA) and is categorized as a grade III tumor. Clinical and genetic factors associated with malignant transformation remain unclear. In particular, typical genetic expression patterns in PXA and A-PXA remain unidentified. CASE DESCRIPTION: We present a case of recurrent PXA in which malignant transformation followed a promoter mutation in TERT. In this case, genetic chronologic changes accompanying malignant transformation of PXA were thoroughly examined. The promoter mutation was detected in the second operative specimen after stereotactic radiosurgery (SRS) at the first tumor recurrence. Subsequently, a malignant transformation to the A-PXA occurred at the time of the second recurrence, and the tumor repeatedly recurred afterward. CONCLUSIONS: TERT promotor mutations may contribute to the malignant transformation of PXA; the mechanism of this mutation is unknown, but it may have been caused by SRS. Therefore, improvident use of radiation should be avoided to prevent the malignant transformation of PXA.
引用
- Hosono J, Nitta M, Masui K, et al. Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma. World Neurosurg. 2018. PMID: 30599247. doi:10.1016/j.wneu.2018.12.095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。